Study at a glance
Do fewer symptoms mean fewer infections?
Not necessarily. A combined score may include symptoms and antibiotic use. It is different from counting confirmed infections, and repeated events are different from the number of people affected.
What is the difference between resisting illness and recovering from it?
Resistance concerns what happens during a challenge. Recovery concerns what happens afterwards. A symptom score or blood marker cannot describe both completely.
Does raising vitamin D during serious illness prove better recovery?
No. In the large intensive-care trial discussed here, vitamin D levels rose without a demonstrated survival benefit. A biological response and a useful clinical outcome must be assessed separately.
Why do observation periods and harms matter?
Occasional questions can miss illness between visits. Benefits also need to be considered alongside harms, including the increased falls seen in one trial of care-home residents.
Read the full article below ↓Resistance and recovery describe different parts of resilience. Resistance concerns what happens during a challenge; recovery concerns what happens afterwards. In vitamin D research, symptom scores, infection counts, blood measurements and hospital outcomes each provide only part of that picture. This page explains how to keep their meanings distinct.
A symptom score is not an infection count
A combined score may include cough, other symptoms and antibiotic use. It can capture the burden of illness, but a lower score does not necessarily mean fewer confirmed infections. In Bergman’s trial, antibiotic use contributed importantly to the favourable combined result. The score should retain that meaning rather than being renamed a direct measurement of immune strength.
An event count differs again. Ginde’s trial recorded respiratory events and falls in older care residents. One person could experience several events. Reporting events as the number of people affected would change the result. The respiratory benefit also cannot be evaluated fairly while ignoring the fall signal.
The observation window matters
A questionnaire about illness in the previous few days does not record every episode over a year. VITAL used brief recent-illness questions at annual contacts. That provides useful evidence for the sampled outcome, but not continuous surveillance of recurrent infection. Long treatment duration and complete event observation are different features of a study.
The broader concept of Vitamin D and Adaptive Capacity involves adjusting to changing demands. A trial with a narrow observation window may contribute to that question without measuring the whole capacity. The review of repeated respiratory challenges is Vitamin D and Immune Robustness During Repeated Respiratory Challenges: Full Evidence Review.
A biological response does not establish recovery
Quraishi’s small sepsis trial measured vitamin D and an antimicrobial peptide, a small protein involved in defence. A change in that protein is a biological finding. It does not alone show that a patient recovered faster, regained normal immune function or survived longer.
Vitamin D and Immune Modulation introduces regulation of immune activity. A regulation claim requires more than any measurable change: its direction, timing and relationship to function matter. In VIOLET, blood vitamin D rose without a demonstrated survival benefit. The biochemical result and the clinical result should both remain visible.
Hospital outcomes matter without identifying a mechanism
Leaving hospital earlier, surviving and returning to ordinary activities are meaningful outcomes. They can reflect several body systems and aspects of care. Even if an intervention changes one of them, that alone does not establish that an immune pathway caused the difference. This is why Vitamin D and Systemic Resilience is a broader subject than one laboratory measurement.
The serious-illness comparison is Vitamin D, Serious-Illness Recovery and the Limits of Immune Resilience Claims: Full Evidence Review. It asks whether clinical outcomes and biological measurements support a claim of restored immune competence. A favourable result in one category cannot fill a missing result in another. The useful question is always what the study directly demonstrated, followed by what remains an inference.
Sources
Related reading
Vitamin D, Serious-Illness Recovery and the Limits of Immune Resilience Claims: Full Evidence Review
Critical-care, sepsis and COVID-19 studies distinguish vitamin D changes from recovery, survival and proof of restored immune function.
Read more →Vitamin D, Serious-Illness Recovery and the Limits of Immune Resilience Claims: Study Summary
A plain-English account of vitamin D in hospital and sepsis studies, including null recovery results, small biomarker findings and uncertainty.
Read more →Vitamin D and Immune Robustness During Repeated Respiratory Challenges: Full Evidence Review
Trials of vitamin D during recurrent respiratory illness, older adulthood and training stress: benefits, null findings, falls and measurement limits.
Read more →Vitamin D and Immune Robustness During Repeated Respiratory Challenges: Study Summary
A clear summary of respiratory studies: some small trials found benefits, larger trials were null, and one older-adult trial reported more falls.
Read more →How to Interpret Vitamin D, Muscle Strength and Falls
A guide to reading muscle mechanisms, performance tests and fall trials without confusing receptor biology with supplement efficacy.
Read more →A comparative study of the injury patterns and inflammatory response between suicidal and unintentional falls from height in Germany
This study aims to analyse injury patterns, inflammatory responses and complication rates in people who have jumped to their death, compared to those who have fallen unintentionally.
Original paper ↗Read more →Association between Frailty, Osteoporosis, Falls and Hip Fractures among Community-Dwelling People Aged 50 Years and Older in Taiwan: Results from I-Lan Longitudinal Aging Study
This study aimed to evaluate the epidemiology of frailty among community-dwelling middle-aged and elderly population and to explore its association with musculoskeletal health in Taiwan.
Original paper ↗Read more →Association of Bone Mass, Falls, and Vertebral Fractures in Older Patients on Hemodialysis: The Role of Comprehensive Geriatric Assessment
Participants had multiple comorbidities, typical of this population, including anemia, cardiovascular disease and chronic liver disease.
Original paper ↗Read more →Effect of Monthly 100,000 IU Vitamin D Supplementation on Falls and Non-Vertebral Fractures
In this study, we aim to establish the role of vitamin D supplements in minimizing the burden of falls and non-vertebral fractures in the elderly population in a local setting.
Original paper ↗Read more →Evaluating the impact of a falls prevention community of practice in a residential aged care setting: a realist approach
Participants were 20 interdisciplinary staff nominating as CoP members between Nov 2013-Nov 2015 representing 13 facilities (approximately 780 beds) of a RAC organisation.
Original paper ↗Read more →Falls and potential therapeutic interventions among elderly and older adult patients with cancer: a systematic review
The aim of this study was to perform a systematic review for previous publications that have assessed the incidence, risk factors, and favorable procedures to prevent and manage falls among cancer survivors of elderly and older adults.
Original paper ↗Read more →Falls, fracture and frailty risk in multiple sclerosis: a Mendelian Randomization study to identify shared genetics
Our objective is to identify shared pleiotropic genetic effects and estimate the causal relationship between MS and musculoskeletal disorders.
Original paper ↗Read more →Implementing STEADI for routine falls prevention of all older adults attending outpatient physical therapy: key partner perspectives
Participants included physical therapy providers (n = 16), physicians (n = 5), administrative staff (n = 3), patients (n = 10), and care partners (n = 10).
Original paper ↗Read more →Multidisciplinary care pathways for falls prevention in older adults: visualizing the needs of primary care-based health care professionals
The aim of this study was to gain insight into and visualize the needs of primary care-based health care professionals with regards to multidisciplinary falls prevention care using journey mapping.
Original paper ↗Read more →Prevalence and Associated Factors of Falls among Older Adults between Urban and Rural Areas of Shantou City, China
Methods: We used cluster random sampling to investigate the sociodemographic information, living habits, medical status, falls, home environment, and balance ability among 649 older adult participants.
Original paper ↗Read more →Sex differences in impact of sarcopenia on falls in community-dwelling Korean older adults
This study aimed to investigate the sex differences in the impact of sarcopenia, defined by the Asian Working Group for Sarcopenia (AWGS), on falls in Korean older adults.
Original paper ↗Read more →The association of FRAX with predictors of falls in the assessment of postmenopausal osteoporosis in Turkey: the fracture study of Turkey (FRACT study)
This observational, descriptive, and cross-sectional study aimed to assess the fall risk predictors and explore their association with FRAX in Turkish patients with postmenopausal osteoporosis.
Original paper ↗Read more →The role of quadriceps muscle strength in the development of falls in the elderly people, a cross-sectional study
The aim of this study was to determine the association between quadriceps muscle strength (QMS) and falls in the elderly subjects.
Original paper ↗Read more →Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data: Full Evidence Review
Individual participant data meta-analysis examining vitamin D exposure and immune robustness under repeated respiratory infection stress.
Read more →Effect of test-and-treat vitamin D supplementation on SARS-CoV-2 vaccine efficacy and immunogenicity (CORONAVIT; Jolliffe et al., 2022): Full Evidence Review
Detailed analysis of a randomized controlled trial examining vitamin D supplementation and its effects on SARS-CoV-2 vaccine immunogenicity and efficacy in adults with sub-optimal vitamin D status.
Read more →Original sources
Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study
Bergman et al. (2012).
Publication details
Bergman et al. (2012). Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open. 2(6):e001663. DOI: 10.1136/bmjopen-2012-001663.
High Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial
Ginde et al. (2017). High Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial.
Publication details
Ginde et al. (2017). High Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial. Journal of the American Geriatrics Society. 65(3):496 to 503. DOI: 10.1111/jgs.14679.
Effect of Daily Vitamin D Supplementation on Risk of Upper Respiratory Infection in Older Adults: A Randomized Controlled Trial
Camargo et al. (2024).
Publication details
Camargo et al. (2024). Effect of Daily Vitamin D Supplementation on Risk of Upper Respiratory Infection in Older Adults: A Randomized Controlled Trial. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 78(5):1162 to 1169. DOI: 10.1093/cid/ciad770.
Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: A randomized, placebo-controlled trial
Quraishi et al. (2015).
Publication details
Quraishi et al. (2015). Effect of cholecalciferol supplementation on vitamin D status and cathelicidin levels in sepsis: A randomized, placebo-controlled trial. Critical care medicine. 43(9):1928 to 1937. DOI: 10.1097/CCM.0000000000001148.
Early High-Dose Vitamin D3 for Critically Ill, Vitamin D–Deficient Patients
Ginde et al., for the VIOLET investigators (2019).
Publication details
Ginde et al., for the VIOLET investigators (2019). Early High-Dose Vitamin D3 for Critically Ill, Vitamin D: Deficient Patients. The New England journal of medicine. 381(26):2529 to 2540. DOI: 10.1056/NEJMoa1911124.